KPC was particularly eyeing investments in refineries related to petrochemicals, he said.

Experts say while KPC blood infections are rare, they are difficult to treat.

In the past decade, KPC has evolved the ability to withstand every known antibiotic.

The risk of emergence of gentamicin-resistant KPC-Kp should be considered.

Therapy with a Trk inhibitor together with gemcitabine also increased survival of KPC mice.